Histogen Inc reports results for the quarter ended in March - Earnings Summary

Histogen

11/05/2023 23:01

* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of 81
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 76
cents per share.
    * Revenue fell 99.9% to $5.00 thousand from a year ago;
analysts
expected zero. 
    * Histogen Inc's reported EPS for the quarter was a loss
of 81
cents​.
    * The mean earnings estimate of analysts had risen by
about 48.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Histogen Inc shares had fallen by 33.3% this quarter and
lost 2.8% so far this year.
    * The company reported a quarterly loss of $3.47 million.
    * Wall Street's median 12-month price target for Histogen
Inc is
$2.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 10:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.76          -0.81          Missed
 Dec. 31 2022      -0.79          -0.61          Beat
 Sep. 30 2022      -1.26          -1.01          Beat
 Jun. 30 2022      -1.70          -1.55          Beat